915087-26-2 Usage
General Description
4-(1-Cyanocyclobutylamino)-2-fluoro-N-methylbenzamide is a chemical compound with a complex molecular structure. It is composed of a fluorine atom and a methyl group attached to a benzene ring, as well as a cyanocyclobutylamino group. 4-(1-CYANOCYCLOBUTYLAMINO)-2-FLUORO-N-METHYLBENZAMIDE is commonly used in pharmaceutical research and development, particularly in the study of potential medications for a wide range of conditions. Its unique structure and potential pharmacological properties make it a valuable tool for investigating new drug candidates. Additionally, this compound may have potential applications in medical imaging and diagnostic techniques due to its ability to interact with biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 915087-26-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,5,0,8 and 7 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 915087-26:
(8*9)+(7*1)+(6*5)+(5*0)+(4*8)+(3*7)+(2*2)+(1*6)=172
172 % 10 = 2
So 915087-26-2 is a valid CAS Registry Number.
915087-26-2Relevant articles and documents
Process for the preparation of 4-[7-(6-Cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7- diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide and its polymorphs
-
Page/Page column 10; 15, (2021/06/22)
The present application relates a process for the preparation of 4- [7 - (6-Cyano- 5- trifluoro methyl pyridin-3- yl) -8- oxo -6- thioxo- 5,7- diazaspiro [3.4] oct-5- yl]- 2-fluoro-N-methyl benzamide of formula-1. The present application further discloses a processes for the preparation of amorphous and crystalline form of compound of formula-1. Formula-1.
SOLID STATE FORMS OF APALUTAMIDE
-
Paragraph 0150, (2018/07/05)
Disclosed are solid state forms of Apalutamide and salts thereof, processes for preparation thereof and pharmaceutical compositions thereof.
Substituted diazaspiroalkanes as androgen receptor modulators
-
, (2016/08/10)
This invention provides for compounds of the Formula II: wherein A, B, Het, R1, R2 and R3 are as described herein. These compounds are androgen receptor modulators useful for the treatment of androgen receptor-associated conditions.